Validation of a new tool to assess health-related quality of life in psoriasis: the PSO-LIFE questionnaire

Health and Quality of Life Outcomes

Volumn 10, Issue , 2012, Pages

  Dauden, Esteban ^a   Herrera, Enrique ^b   Puig, Lluis ^c   Sánchez Carazo, José L ^d   Toribio, Jaime ^e   Caloto, Ma T ^f   Nocea, Gonzalo ^f   Roset, Montse ^f   Lara, Nuria ^g  

^a HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

^c HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^d HOSPITAL GENERAL UNIVERSITARIO DE VALENCIA   (Spain)

^e Hospital Gil Casares   (Spain)

^f MSD   (Spain)

^g IQVIA   (United States)

Author keywords

Psoriasis; Quality of life; Questionnaire; Validation

Indexed keywords

ADULT; ARTICLE; ATOPIC DERMATITIS; CONTROLLED STUDY; DERMATOLOGY QUALITY OF LIFE INDEX; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; OBSERVATIONAL STUDY; PROSPECTIVE STUDY; PSORIASIS; PSORIASIS DISABILITY INDEX; PSORIASIS QUALITY OF LIFE QUESTIONNAIRE; QUALITY OF LIFE; QUALITY OF LIFE INDEX; SENSITIVITY ANALYSIS; SPAIN; TEST RETEST RELIABILITY; URTICARIA;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; FEMALE; FOLLOW-UP STUDIES; HEALTH STATUS INDICATORS; HUMANS; MALE; MIDDLE AGED; OFFICE VISITS; OUTCOME ASSESSMENT (HEALTH CARE); PSORIASIS; PSYCHOMETRICS; QUALITATIVE RESEARCH; QUALITY OF LIFE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SOCIAL CLASS; SPAIN; STATISTICS, NONPARAMETRIC;

EID: 84861330731     PISSN: None     EISSN: 14777525     Source Type: Journal    
DOI: 10.1186/1477-7525-10-56     Document Type: Article

References (29)

1. Eghlileb AM, Davies EE, Finlay AY. Psoriasis has a major secondary impact on the lives of family members and partners. Br J Dermatol 2007, 156:1245-1250. 10.1111/j.1365-2133.2007.07881.x, 17459044.
2. Bhosle MJ, Kulkarni A, Feldman SR, Balkrishnan R. Quality of life in patients with psoriasis. Health Qual Life Outcomes 2006, 4:35. 10.1186/1477-7525-4-35, 1501000, 16756666.
3. de Korte J, Sprangers MA, Mombers FM, Bos JD. Quality of life in patients with psoriasis: a systematic literature review. J Investig Dermatol Symp Proc 2004, 9:140-147. 10.1046/j.1087-0024.2003.09110.x, 15083781.
4. Müller H, Brockow T, Franke A, Resch FL, Calliess IT, Schmid-Ott G. Construct validity of the questionnaire on experience with skin complaints (short form). Identification of a subscale responsive to physical treatment. Eur J Psychological assessment 2007, 23(3):176-184.
5. Sampogna F, Tabolli S, Söderfeldt B, Axtelius B, Aparo U, Abeni D, . IDI Multipurpose Psoriasis Research on Vital Experiences (IMPROVE) investigators Measuring quality of life of patients with different clinical types of psoriasis using the SF-36. Br J Dermatol 2006, 154:844-849. 10.1111/j.1365-2133.2005.07071.x, 16634884, IDI Multipurpose Psoriasis Research on Vital Experiences (IMPROVE) investigators.
6. Lewis VJ, Finlay AY. A critical review of Quality-of-Life Scales for Psoriasis. Dermatol Clin 2005, 23:707-716. 10.1016/j.det.2005.05.016, 16112448.
7. Basra MK, Fenech R, Gatt RM, Salek MS, Finlay AY. The Dermatology Life Quality Index 1994-2007: a comprehensive review of validation data and clinical results. Br J Dermatol 2008, 159:997-1035.
8. Chren MM, Lasek RJ, Flocke SA, Zyzanski SJ. Improved discriminative and evaluative capability of a refined version of Skindex, a quality-of-life instrument for patients with skin diseases. Arch Dermatol 1997, 133:1433-1440. 10.1001/archderm.1997.03890470111018, 9371029.
9. Finlay AY, Khan GK, Luscombe DK, Salek MS. Validation of sickness impact profile and psoriasis disability index in psoriasis. Br J Dermatol 1990, 123:751-756. 10.1111/j.1365-2133.1990.tb04192.x, 2265090.
10. Nijsten T, Unaeze J, Stern RS. Refinement and reduction of the Impact of Psoriasis Questionnaire: classical test theory vs. Rasch analysis. Br J Dermatol 2006, 154:692-700. 10.1111/j.1365-2133.2005.07066.x, 16536813.
11. Inanir I, Aydemir O, Gündüz K, Danaci AE, Türel A. Developing a quality of life instrument in patients with psoriasis: the Psoriasis Quality of Life Questionnaire (PQLQ). Int J Dermatol 2006, 45:234-238. 10.1111/j.1365-4632.2005.02448.x, 16533221.
12. McKenna SP, Cook SA, Whalley D, Doward LC, Richards HL, Griffiths CE, Van Assche D. Development of the PSORIQoL, a psoriasis-specific measure of quality of life designed for use in clinical practice and trials. Br J Dermatol 2003, 149:323-331. 10.1046/j.1365-2133.2003.05492.x, 12932239.
13. Gupta MA, Gupta AK. The psoriasis life stress inventory: a preliminary index of psoriasis-related stress. Acta Derm Venereol 1995, 75:240-243.
14. Schmid-Ott G, Jaeger B, Kuensebeck HW, Ott R, Lamprecht F. Dimensions of stigmatization in patients with psoriasis in a " Questionnaire on Experience with Skin Complaints'. Dermatology 1996, 193:304-310. 10.1159/000246275, 8993954.
15. Badia X, Mascaró JM, Lozano R, . the CAVIDE Research Group Measuring health-related quality of life in patients with mild to moderate exzema and psoriasis: clinical validity, reliability, and sensitivity to change of the DLQI. Br J Dermatol 1999, 141:698-702. 10.1046/j.1365-2133.1999.03112.x, 10583119, the CAVIDE Research Group.
16. Vanacolocha F, Puig L, Daudén E, Escudero J, Herranz JM, Ferrándiz C, Febrer I, Lizán L, Badia X. Validation of the Spanish version of the psoriasis disability Index questionnaire in assessing the quality of life of patients with moderate-severe psoriasis. Actas Dermosifiliogr 2005, 96:659-668. 10.1016/S0001-7310(05)73154-9, 16476316.
17. Herdman M, Fox-Rushby J, Badía X. A model of equivalence in the cultural adaptation of HRQOL instruments: the universalist approach. Qual Life Res 1998, 7:323-335. 10.1023/A:1008846618880, 9610216.
18. Sanchez-Carazo JL, Dauden E, Herrera E, Toribio J, Puig L, Sabater J, Perulero N, Badia X. Development of a new measure for assessing health-related quality of life in patients with psoriasis: PSO-LIFE 2009, Poster presented at the 12th Annual European Congress of the International Society for Pharmacoeconomics and Outcomes Research, Paris, October.
19. Griffiths CE, Christophers E, Barker JN, Chalmers RJ, Chimenti S, Krueger GG, Leonardi C, Menter A, Ortonne JP, Fry L. A classification of psoriasis vulgaris according to phenotype. Br J Dermatol 2007, 156:258-262. 10.1111/j.1365-2133.2006.07675.x, 17223864.
20. Guidance for industry. Patient-reported outcome measures: use in medical product development to support labeling claims , , Available at: http://www.fda.gov/drugs/GuidanceComplianceRegulatoryInformation/Guidances.
21. Assessing health status and quality-of-life instruments: attributes and review criteria. Qual Life Res 2002, 11:193-205. 10.1023/A:1015291021312, 12074258.
22. Cattell RB. The scree test for the number of factors. Multivariate Behav Res 1966, 1:629-637.
23. Hays RD, Anderson R, Revicki D. Psychometric considerations in evaluating health-related quality of life measures. Qual Life Res 1993, 2:441-449. 10.1007/BF00422218, 8161978.
24. Cohen J. Statistical Power Analysis for the Behavioral Sciences (2nd ed) 1988, L. Erlbaum Associates, Hillsdale.
25. Jaeschke R, Singer J, Guyatt GH. Measurement of health status. Ascertaining the minimal clinically important difference. Control Clin Trials 1989, 10:407-415. 10.1016/0197-2456(89)90005-6, 2691207.
26. Meyer N, Paul C, Feneron D, Bardoulat I, Thiriet C, Camara C, Sid-Mohand D, Le Pen C, Ortonne JP. Psoriasis: an epidemiological evaluation of disease burden in 590 patients. J Eur Acad Dermatol Venereol 2010, 24:1075-1082.
27. Shikiar R, Bresnahan BW, Stone SP, Thompson C, Koo J, Revicki DA. Validity and reliability of patient reported outcomes used in psoriasis: results from two randomized clinical trials. Health Qual Life Outcomes 2003, 1:53. 10.1186/1477-7525-1-53, 269993, 14613569.
28. Bronsard V, Paul C, Prey S, Puzenat E, Gourraud PA, Aractingi S, Aubin F, Bagot M, Cribier B, Joly P, Jullien D, Le Maitre M, Richard-Lallemand MA, Ortonne JP. What are the best outcome measures for assessing quality of life in plaque type psoriasis? A systematic review of the literature. J Eur Acad Dermatol Venereol 2010, 24(Suppl 2):17-22.
29. Guyatt GH, Norman GR, Juniper EF, Griffith LE. A critical look at transition ratings. J Clin Epidemiol 2002, 55:900-908. 10.1016/S0895-4356(02)00435-3, 12393078.